AM-101 in the Treatment of Acute Tinnitus 3

Summary

The purpose of this research study is to test the safety and effectiveness of the study drug, AM-101. AM-101 is tested for the treatment of tinnitus that started as the result of an injury to the inner ear or due to middle ear inflammation (otitis media). Subjects with tinnitus can take part in the study, if their tinnitus started within the last 3 months or within the last \>3 to 6 months.

Timeline

Start

2014-01

Primary completion

2017-12-28

Completion

2017-12-28

Drugs

Indications